Therefore, we hypothesized SLE patients may have autoantibodies (Abs) against AHNAK1 because anti‐AHNAK1 antibodies possibly are able to interfere with Ca2+ signaling through binding to AHNAK1, subsequently resulting in aberrant T cells signal transduction. This evidence concerns the gene AHNAK and systemic lupus erythematosus.